FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093334593> ?p ?o ?g. }

• W2093334593 endingPage "58" @default.
• W2093334593 startingPage "51" @default.
• W2093334593 abstract "Zanamivir, a clinically proven potent and specific inhibitor of influenza A and B neuraminidase, has been approved in some countries for the treatment of influenza and is in late-stage development for the prophylaxis of influenza. This study investigated whether the coadministration of zanamivir and influenza vaccine affected the development of antibody responses to injected influenza haemagglutinin.This double-blind randomised placebo-controlled study compared the antihaemagglutinin antibody production [haemagglutination inhibition (HAI) titre] after administration of inactivated trivalent influenza vaccine in healthy volunteers receiving zanamivir or placebo once daily for 28 days.138 healthy volunteers (52 men and 86 nonpregnant women, mean age 32.7 years) were randomised to the zanamivir (70 participants) or placebo (68 participants) groups.Participants received a single intramuscular dose (deltoid muscle) of the 1997/1998 trivalent inactivated influenza vaccine (surface antigen) PhEur (Fluvirin) on day 1, and were then randomised to receive zanamivir 10 mg/day by oral inhalation or placebo for 28 days. Serum samples for determination of HAI titres were obtained before vaccination and on days 15 and 29. Compliance, adverse events and laboratory parameters were monitored.The primary measure of response was the geometric mean increase in HAI titre against the 3 viral antigens contained in the vaccine, calculated as the ratio of the value 4 weeks after vaccination to the baseline value. The means (and 2-sided 95% confidence intervals) for the ratio between the geometric mean increase with placebo and the increase with zanamivir were as follows: 1.1 (0.7, 1.5) for influenza B, 0.7 (0.4, 1.2) for influenza A H1N1, and 0.6 (0.4, 1.1) for influenza AH3N2. (This corresponds to a test level of alpha = 0.025 for the hypothesis that the increase with placebo was > or = 2-fold greater than the increase with zanamivir.) A lack of effect was concluded as values of 2.0 or greater (i.e. a 2-fold difference) were excluded. Comparisons were also made of the increase in titre at 2 weeks, the proportions of participants with at least a 4-fold increase in titre and the proportions of participants with a titre of at least 1:40. These comparisons revealed no differences between zanamivir- and placebo-treated groups. The nature and incidence of adverse events observed with zanamivir were similar to those observed with placebo.Overall, zanamivir was not associated with a reduced response in HAI titre against the 3 vaccine antigens when compared with placebo. In addition, zanamivir was well tolerated. Inhaled zanamivir 10 mg once daily has been demonstrated to prevent symptomatic laboratory-confirmed influenza in a community outbreak. Zanamivir should have the potential to provide protection during the 2- to 4-week period before full immunity is induced, following vaccination at a time when influenza is circulating in the community." @default.
• W2093334593 created "2016-06-24" @default.
• W2093334593 creator A5002183784 @default.
• W2093334593 creator A5012458632 @default.
• W2093334593 creator A5012527513 @default.
• W2093334593 creator A5046389093 @default.
• W2093334593 date "1999-01-01" @default.
• W2093334593 modified "2023-10-10" @default.
• W2093334593 title "Coadministration of Orally Inhaled Zanamivir with Inactivated Trivalent Influenza Vaccine Does Not Adversely Affect the Production of Antihaemagglutinin Antibodies in the Serum of Healthy Volunteers" @default.
• W2093334593 cites W1808739935 @default.
• W2093334593 cites W1875180613 @default.
• W2093334593 cites W1966349418 @default.
• W2093334593 cites W2024412216 @default.
• W2093334593 cites W2058290736 @default.
• W2093334593 cites W2065485732 @default.
• W2093334593 cites W2067727963 @default.
• W2093334593 cites W2069091142 @default.
• W2093334593 cites W2086358466 @default.
• W2093334593 cites W2115959170 @default.
• W2093334593 cites W2334261876 @default.
• W2093334593 doi "https://doi.org/10.2165/00003088-199936001-00006" @default.
• W2093334593 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10429840" @default.
• W2093334593 hasPublicationYear "1999" @default.
• W2093334593 type Work @default.
• W2093334593 sameAs 2093334593 @default.
• W2093334593 citedByCount "48" @default.
• W2093334593 countsByYear W20933345932012 @default.
• W2093334593 countsByYear W20933345932013 @default.
• W2093334593 countsByYear W20933345932016 @default.
• W2093334593 countsByYear W20933345932017 @default.
• W2093334593 countsByYear W20933345932019 @default.
• W2093334593 crossrefType "journal-article" @default.
• W2093334593 hasAuthorship W2093334593A5002183784 @default.
• W2093334593 hasAuthorship W2093334593A5012458632 @default.
• W2093334593 hasAuthorship W2093334593A5012527513 @default.
• W2093334593 hasAuthorship W2093334593A5046389093 @default.
• W2093334593 hasBestOaLocation W20933345931 @default.
• W2093334593 hasConcept C126322002 @default.
• W2093334593 hasConcept C134164806 @default.
• W2093334593 hasConcept C142724271 @default.
• W2093334593 hasConcept C159654299 @default.
• W2093334593 hasConcept C162156334 @default.
• W2093334593 hasConcept C197934379 @default.
• W2093334593 hasConcept C203014093 @default.
• W2093334593 hasConcept C204787440 @default.
• W2093334593 hasConcept C22070199 @default.
• W2093334593 hasConcept C2522874641 @default.
• W2093334593 hasConcept C27081682 @default.
• W2093334593 hasConcept C2777451964 @default.
• W2093334593 hasConcept C2777538117 @default.
• W2093334593 hasConcept C2779134260 @default.
• W2093334593 hasConcept C2780689484 @default.
• W2093334593 hasConcept C2781442963 @default.
• W2093334593 hasConcept C3008058167 @default.
• W2093334593 hasConcept C32611913 @default.
• W2093334593 hasConcept C524204448 @default.
• W2093334593 hasConcept C71924100 @default.
• W2093334593 hasConceptScore W2093334593C126322002 @default.
• W2093334593 hasConceptScore W2093334593C134164806 @default.
• W2093334593 hasConceptScore W2093334593C142724271 @default.
• W2093334593 hasConceptScore W2093334593C159654299 @default.
• W2093334593 hasConceptScore W2093334593C162156334 @default.
• W2093334593 hasConceptScore W2093334593C197934379 @default.
• W2093334593 hasConceptScore W2093334593C203014093 @default.
• W2093334593 hasConceptScore W2093334593C204787440 @default.
• W2093334593 hasConceptScore W2093334593C22070199 @default.
• W2093334593 hasConceptScore W2093334593C2522874641 @default.
• W2093334593 hasConceptScore W2093334593C27081682 @default.
• W2093334593 hasConceptScore W2093334593C2777451964 @default.
• W2093334593 hasConceptScore W2093334593C2777538117 @default.
• W2093334593 hasConceptScore W2093334593C2779134260 @default.
• W2093334593 hasConceptScore W2093334593C2780689484 @default.
• W2093334593 hasConceptScore W2093334593C2781442963 @default.
• W2093334593 hasConceptScore W2093334593C3008058167 @default.
• W2093334593 hasConceptScore W2093334593C32611913 @default.
• W2093334593 hasConceptScore W2093334593C524204448 @default.
• W2093334593 hasConceptScore W2093334593C71924100 @default.
• W2093334593 hasIssue "Supplement 1" @default.
• W2093334593 hasLocation W20933345931 @default.
• W2093334593 hasLocation W20933345932 @default.
• W2093334593 hasOpenAccess W2093334593 @default.
• W2093334593 hasPrimaryLocation W20933345931 @default.
• W2093334593 hasRelatedWork W2038899530 @default.
• W2093334593 hasRelatedWork W2063224363 @default.
• W2093334593 hasRelatedWork W2132657130 @default.
• W2093334593 hasRelatedWork W2134668430 @default.
• W2093334593 hasRelatedWork W2159382969 @default.
• W2093334593 hasRelatedWork W2290667214 @default.
• W2093334593 hasRelatedWork W2329292478 @default.
• W2093334593 hasRelatedWork W2358831769 @default.
• W2093334593 hasRelatedWork W2522196832 @default.
• W2093334593 hasRelatedWork W2892230840 @default.
• W2093334593 hasVolume "36" @default.
• W2093334593 isParatext "false" @default.
• W2093334593 isRetracted "false" @default.
• W2093334593 magId "2093334593" @default.
• W2093334593 workType "article" @default.